Larimar Therapeutics Inc (LRMR) News & EventsLRMRLarimar Therapeutics Inc

Larimar Submits Biologics License Application for nomlabofusp

"This is a defining period for Larimar as we advance nomlabofusp toward potential approval, supported by a clear path to submission, a robust data package, and continued clinical momentum," said Carole Ben-Maimon, MD, President and Chief Executive Officer of Larimar. "Open label study data announced in June further reinforce the disease-modifying potential of nomlabofusp, demonstrating continued directional improvements in key clinical endpoints over time alongside a well-characterized safety profile. Following receipt of minutes from a successful Type B multidisciplinary pre-BLA meeting with the Food and Drug Administration, the first module of our rolling Biologics License Application has been submitted, with completion expected in the second half of 2026. We continue to see strong enthusiasm from patients and investigators as we advance the OL study with additional participants dosed in July and several adults and adolescents in screening. We are also on track to initiate dosing in our global confirmatory study this quarter. Looking ahead, we are focused on execution as we work to bring forward nomlabofusp as the first potential therapy to address the underlying cause of disease for pediatric and adult patients living with Friedreich's ataxia."

Nasdaq Rises 0.2% as Tech Stocks Rebound

Investors bought the early-session dip in the Tech space on Wednesday, helping the sector join Energy as the only two areas of the market to register gains.  Consequently, Nasdaq Composite finished the day up 0.2% and S&P 500 was well off the intra-day lows to end the session down just 0.3%, rising above 7,480 into the close after dipping as low as 7,420 earlier.  Semiconductors, memory, and servers were especially strong within the broader AI bounce-back theme, while Software stocks softened after Tuesday's rally.  Large-cap Growth performance also exceeded that of SMID and Value.Markets remain on edge however, with volatility in the Tech arena compounded by the ongoing geopolitical concerns.  Headlines questioning whether the overall state of U.S.-Iran ceasefire can be preserved after the two sides exchanged attacks over the past 48 hours have propped up Energy prices.  In the evening session, WTI Crude Oil is now above $74 per barrel.  S&P e-minis and Nasdaq 100 index futures are down by about a decimal.  Precious metals also remain under pressure, with higher oil price narrative and its inflationary implications supporting the US Dollar vis-a-vis an up-creep in yields and assumptions of tighter-for-longer Fed policy.  This was further reinforced in today's FOMC minutes from last month's meeting tilting decidedly more hawkish.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER AFTER EARNINGS -AZZ Inc.up 8.3%ALSO HIGHER -Ampco-Pittsburghup 13.7% after announcing increase in customer order activityLarimar Therapeuticsup 3.3% after insider buyAeroVironmentup 1.2% after providing medium-term targetsDOWN AFTER EARNINGS -Levi Straussdown 6.0%PriceSmartdown 2.7%ALSO LOWER -MDA Space Ltd.down 6.9% after equity offeringCostco Wholesaledown 1.2% after June comps data

Major Averages Finish Broadly Higher as Investors Await Middle East News

The major averages finished broadly higher as investors await news out of the Middle East. President Trump said the U.S. and Iran will meet to negotiate after days of strikes as the market shifts focus from geopolitics back toward macro data. Investors are watching labor market releases, including the JOLTS report and Thursday's payroll report, for clues on the Federal Reserve path. Markets continue to weigh a resilient economy against concerns that sticky inflation could keep the Fed more restrictive than expected.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:SpaceXwillon July 7Comcastplans to separate intothrough a tax-free spin-off of NBCUniversal and SkySpaceXand Charterhave discussed partnering on a mobile phone offering,Verizonand BT Groupwilland combine international operationsRocket LabIridiumfor $54 per share in a cash and stock transaction2. WALL STREET CALLS:Robloxto Buy at AreteAdobeto Neutral at Phillip SecuritiesDoximityto Underperform from Buy at BofAQuantinuumwith mostly Buy or equivalent ratings as Wall Street rolled out coverageCoverage of Liftoff Mobilewas alsowith mostly bullish ratings3. AROUND THE WEB:Carlislehas made unsolicited offers for Owens Corning, WSJ reportsEli Lillyand Regeneronare among the first selections for the FDA's PreCheck program, CNBC reportsAmazoncould pay more for Anthropic's technology, The Information reportsIntelis gaining momentum from the AI boom and new partnerships with Nvidia, Apple, and Elon Musk's Terafab project, but its long-term future depends on proving its new 14A manufacturing process can succeed and help restore U.S. chip production, New York Times reportsSamsungand SK Hynix intend to invest over $500B in a new chip-making hub in South Korea, WSJ says4. MOVERS:Repay Holdingsincreases after Forager Fundthe company for $5.25 per shareFuelCellgains after B. Rileythe stock to BuyPalisade Biohigher afterto start its ulcerative colitis studyEvommunelower after Phase 2b trial of EVO756Larimar Therapeuticsfalls afterof its rolling BLA for nomlabofusp5. EARNINGS/GUIDANCE:GameStopprovidedPerfect Moment, with EPS and revenue higher year-over-yearKolibri Global EnergyprovidedNiketoon June 30Constellation Brandstoon June 30INDEXES:The Dow rose 306.63, or 0.59%, to 52,182.74, the Nasdaq gained 522.53, or 2.07%, to 25,820.15, and the S&P 500 advanced 86.41, or 1.18%, to 7,440.43.